Australia Oligonucleotide Cdmo Market Size & Outlook

Name: Australia Oligonucleotide Cdmo Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The oligonucleotide cdmo market in Australia is expected to reach a projected revenue of US$ 87.5 million by 2033. A compound annual growth rate of 16.08% is expected of Australia oligonucleotide cdmo market from 2026 to 2033.

Australia oligonucleotide cdmo service outlook (Revenue, USD million, 2021-2033)
- Contract Manufacturing
- Contract Development
Australia oligonucleotide cdmo type outlook (Revenue, USD million, 2021-2033)
- Antisense Oligonucleotides
- Small Interfering RNA
- Other Oligonucleotides
Australia oligonucleotide cdmo application outlook (Revenue, USD million, 2021-2033)
- Therapeutic
- Research
- Diagnostic
Australia oligonucleotide cdmo end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical and Biopharmaceutical Companies
- Diagnostic Companies
- Others End Use

Australia Oligonucleotide Cdmo Market Size & Outlook

Sign up - it's easy, and free!